Business · 01/06/2026
FDA Announces Draft Guidance for Streamlined Nonclinical Safety Studies for Oncology Pharmaceuticals
The FDA is releasing a draft guidance to help pharmaceutical companies develop cancer treatments with reduced animal testing, building on lessons learned during the COVID-19 pandemic.